Publications:

---

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells.

Translational Cancer Research

Li, Amin A; Cao, Weiya W; Liu, Xueke X; Zhang, Yinci Y; Ma, Yongfang Y; Xu, Ruyue R; Tang, Xiaolong X

Publication Date: 2020-09

Variant appearance in text: EGFR: H358R

PubMed Link: 35117912

Variant Present in the following documents:

• tcr-09-09-5473.pdf

View BVdb publication page

---

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer.

Investigational New Drugs

Plangger, Adelina A; Rath, Barbara B; Hochmair, Maximilian M; Funovics, Martin M; Neumayer, Christoph C; Zeillinger, Robert R; Hamilton, Gerhard G

Publication Date: 2022-04

Variant appearance in text: EGFR: H358R

PubMed Link: 34596822

Variant Present in the following documents:

• 10637_2021_Article_1181.pdf

View BVdb publication page

---

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells.

Journal Of Cancer Research And Clinical Oncology

Li, Amin A; Cao, Weiya W; Liu, Xueke X; Zhang, Yinci Y; Ma, Yongfang Y; Xu, Ruyue R; Zhang, Rongbo R; Liu, Xinkuang X; Zhou, Shuping S; Wang, Ruikai R; Liu, Jiachang J; Tang, Xiaolong X

Publication Date: 2020-07

Variant appearance in text: EGFR: H358R

PubMed Link: 32342201

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Rab25-Mediated EGFR Recycling Causes Tumor Acquired Radioresistance.

Iscience

Zhang, Lu L; Xie, Bowen B; Qiu, Yanfang Y; Jing, Di D; Zhang, Jing J; Duan, Yumei Y; Li, Zhi Z; Fan, Ming M; He, Jiang J; Qiu, Yuanzheng Y; Tan, Rong R; Li, Jian Jian JJ; Sun, Lun-Quan LQ

Publication Date: 2020-04-24

Variant appearance in text: EGFR: H358R

PubMed Link: 32252020

Variant Present in the following documents:

• Main text
• mmc1.pdf
• main.pdf

View BVdb publication page

---

HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer.

Oncogenesis

Yang, Haitang H; Liang, Shun-Qing SQ; Xu, Duo D; Yang, Zhang Z; Marti, Thomas M TM; Gao, Yanyun Y; Kocher, Gregor J GJ; Zhao, Heng H; Schmid, Ralph A RA; Peng, Ren-Wang RW

Publication Date: 2019-08-20

Variant appearance in text: EGFR: H358R

PubMed Link: 31431614

Variant Present in the following documents:

• Main text
• 41389_2019_Article_158.pdf
• 41389_2019_158_MOESM1_ESM.pdf

View BVdb publication page

---

Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.

Redox Biology

Xie, Bowen B; Zhang, Lu L; Hu, Wenfeng W; Fan, Ming M; Jiang, Nian N; Duan, Yumei Y; Jing, Di D; Xiao, Wenwu W; Fragoso, Ruben C RC; Lam, Kit S KS; Sun, Lun-Quan LQ; Li, Jian Jian JJ

Publication Date: 2019-06

Variant appearance in text: EGFR: H358R

PubMed Link: 30986607

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Essential Role of DNA Methyltransferase 1-mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Min, Hye-Young HY; Lee, Su-Chan SC; Woo, Jong Kyu JK; Jung, Hyun Jin HJ; Park, Kwan Hee KH; Jeong, Hae Min HM; Hyun, Seung Yeob SY; Cho, Jaebeom J; Lee, Wooin W; Park, Ji Eun JE; Kwon, So Jung SJ; Lee, Hyo-Jong HJ; Ni, Xiao X; Shin, Young Kee YK; Johnson, Faye M FM; Duvic, Madeleine M; Lee, Ho-Young HY

Publication Date: 2017-03-01

Variant appearance in text: EGFR: H358R

PubMed Link: 27582487

Variant Present in the following documents:

• Main text

View BVdb publication page

---